Methylated BCAT1/IKZF1 DNA: a breakthrough in colorectal cancer diagnosis?
- PMID: 38222695
- PMCID: PMC10783255
- DOI: 10.1097/MS9.0000000000001495
Methylated BCAT1/IKZF1 DNA: a breakthrough in colorectal cancer diagnosis?
Conflict of interest statement
Authors have no conflicts of interest to declare.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
References
-
- https://www.cancer.net/cancer-types/colorectal-cancer/statistics Colorectal Cancer: Statistics | Cancer.Net. Accessed 12 January 2023.
-
- Musher BL, Melson JE, Amato G, et al. . Evaluation of circulating tumor DNA for methylated BCAT1 and IKZF1 to detect recurrence of stage II/stage III colorectal cancer (CRC). Cancer Epidemiol Biomarkers Prev 2020;29:2702–2709. - PubMed
Publication types
LinkOut - more resources
Full Text Sources